Literature DB >> 12651118

Expression and purification of the dihydrolipoamide acetyltransferase and dihydrolipoamide dehydrogenase subunits of the Escherichia coli pyruvate dehydrogenase multienzyme complex: a mass spectrometric assay for reductive acetylation of dihydrolipoamide acetyltransferase.

Wen Wei1, Hong Li, Natalia Nemeria, Frank Jordan.   

Abstract

Plasmids were constructed for overexpression of the Escherichia coli dihydrolipoamide acetyltransferase (1-lip E2, with a single hybrid lipoyl domain per subunit) and dihydrolipoamide dehydrogenase (E3). A purification protocol is presented that yields homogeneous recombinant 1-lip E2 and E3 proteins. The hybrid lipoyl domain was also expressed independently. Masses of 45,953+/-73Da (1-lip E2), 50,528+/-5.5Da (apo-E3), 51,266+/-48Da (E3 including FAD), and 8982+/-4.0 (lipoyl domain) were determined by MALDI-TOF mass spectrometry. The purified 1-lip E2 and E3 proteins were functionally active according to the overall PDHc activity measurement. The lipoyl domain was fully acetylated after just 30 s of incubation with E1 and pyruvate. The mass of the acetylated lipoyl domain is 9019+/-2Da according to MALDI-TOF mass spectrometry. Treatment of the 1-lip E2 subunit with trypsin resulted in the appearance of the lipoyl domain with a mass of 10,112+/-3Da. When preincubated with E1 and pyruvate, this tryptic fragment was acetylated according to the mass increase. MALDI-TOF mass spectrometry was thus demonstrated to be a fast and precise method for studying the reductive acetylation of the recombinant 1-lip E2 subunit by E1 and pyruvate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651118     DOI: 10.1016/s1046-5928(02)00674-5

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Nuclear magnetic resonance evidence for the role of the flexible regions of the E1 component of the pyruvate dehydrogenase complex from gram-negative bacteria.

Authors:  Jaeyoung Song; Yun-Hee Park; Natalia S Nemeria; Sachin Kale; Lazaros Kakalis; Frank Jordan
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

2.  Insight to the interaction of the dihydrolipoamide acetyltransferase (E2) core with the peripheral components in the Escherichia coli pyruvate dehydrogenase complex via multifaceted structural approaches.

Authors:  Krishnamoorthy Chandrasekhar; Junjie Wang; Palaniappa Arjunan; Martin Sax; Yun-Hee Park; Natalia S Nemeria; Sowmini Kumaran; Jaeyoung Song; Frank Jordan; William Furey
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

3.  Interchain acetyl transfer in the E2 component of bacterial pyruvate dehydrogenase suggests a model with different roles for each chain in a trimer of the homooligomeric component.

Authors:  Jaeyoung Song; Frank Jordan
Journal:  Biochemistry       Date:  2012-03-22       Impact factor: 3.162

4.  Catalysis in Enzymatic Decarboxylations: Comparison of Selected Cofactor-dependent and Cofactor-independent Examples.

Authors:  Frank Jordan; Hetalben Patel
Journal:  ACS Catal       Date:  2013-07-05       Impact factor: 13.084

5.  Dihydrolipoamide dehydrogenase mutation alters the NADH sensitivity of pyruvate dehydrogenase complex of Escherichia coli K-12.

Authors:  Youngnyun Kim; L O Ingram; K T Shanmugam
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

6.  Formation of reactive oxygen species by human and bacterial pyruvate and 2-oxoglutarate dehydrogenase multienzyme complexes reconstituted from recombinant components.

Authors:  Attila Ambrus; Natalia S Nemeria; Beata Torocsik; Laszlo Tretter; Mattias Nilsson; Frank Jordan; Vera Adam-Vizi
Journal:  Free Radic Biol Med       Date:  2015-10-09       Impact factor: 7.376

7.  Determination of pre-steady-state rate constants on the Escherichia coli pyruvate dehydrogenase complex reveals that loop movement controls the rate-limiting step.

Authors:  Anand Balakrishnan; Natalia S Nemeria; Sumit Chakraborty; Lazaros Kakalis; Frank Jordan
Journal:  J Am Chem Soc       Date:  2012-11-02       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.